Orexigen Therapeutics, Inc. (OREX)
OREXPrice: $0.22
Fair Value: 🔒
🔒score
Description
Shares
| Market Cap | $0 | Exchange | NASDAQ |
| Sector | — | Industry | — |
| Country | — | CEO | — |
| IPO Date | 2007-04-26 | CAGR | 0.94% |
| Employees | — | Website | — |
| Div. Yield | — | Payout Ratio | -0.81% |
| Buy Back Yield | — | Total Yield | — |
OREX chart loading...
Fundamentals
Technicals
| Enterprise Value | $11.94M | P/E Ratio | — |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | — | P/B Ratio | 0.06 |
| P/CF Ratio | -0.03 | P/FCF Ratio | — |
| EPS | — | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 204.09% | Gross Margin | 0.76% |
| Operating Margin | -1.69% | Profit Margin | -0.73% |
| ROE | -0.54% | ROA | -0.08% |
| ROCE | -0.24% | Current Ratio | 3.43 |
| Quick Ratio | 3.08 | Cash Ratio | 1.42 |
| Debt/Equity | 1.39 | Interest Coverage | -7.26 |
| Altman Z Score | — | Piotroski Score | — |